Pei Ho, Nur Nabila Farhana Binte Taufiq Chong Ah Hoo, Yi Xin Cheng, Lingyan Meng, Darryl Chai Min Shen, Boon Wee Teo, Valerie Ma, Carol Anne Hargreaves
{"title":"终末期肾病患者在接受血液透析第一年的临床旅程和透析通路所需的医疗资源。","authors":"Pei Ho, Nur Nabila Farhana Binte Taufiq Chong Ah Hoo, Yi Xin Cheng, Lingyan Meng, Darryl Chai Min Shen, Boon Wee Teo, Valerie Ma, Carol Anne Hargreaves","doi":"10.1177/11297298221095769","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Creation and maintenance of dialysis vascular access (VA) is a major component of healthcare resource utilization and cost for patients newly started on hemodialysis (HD). Different VA format arises due to patient acceptance of anticipatory care versus late preparation, and clinical characteristics. This study reviews the clinical journey and resource utilization required for different VA formats in the first year of HD.</p><p><strong>Method: </strong>Data of patients newly commenced on HD between July 2015 and June 2016 were reviewed. Patients were grouped by their VA format: (A) pre-emptive surgically created VA (SCVA), (B) tunneled central venous catheter (CVC) followed by SCVA creation, (C) long-term tunneled CVC only. Clinical events, number of investigations and procedures, hospital admissions, and incurred costs of the three groups were compared.</p><p><strong>Results: </strong>In the multivariable analysis, the cost incurred by the group A patients had no significant difference to that incurred in the group B patients (<i>p</i> = 0.08), while the cost of group C is significantly lower (<i>p</i> < 0.001). Both the 62.7% of group A with successful SCVA who avoided tunneled CVC usage, and those with a functionally matured SCVA in group B (66.1%), used fewer healthcare resources and incurred less cost for their access compared to those did not (<i>p</i> = 0.01, <i>p</i> = 0.02, respectively) during the first year of HD.</p><p><strong>Conclusion: </strong>With comparable cost, a pre-emptive approach enables avoidance of tunneled CVC. Tunneled CVC only access format incurred lower cost and is suitable for carefully selected patients. Successful maturation of SCVA greatly affects patients' clinical journey and healthcare cost.</p>","PeriodicalId":35321,"journal":{"name":"JAVA - Journal of the Association for Vascular Access","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The clinical journey and healthcare resources required for dialysis access of end-stage kidney disease patients during their first year of hemodialysis.\",\"authors\":\"Pei Ho, Nur Nabila Farhana Binte Taufiq Chong Ah Hoo, Yi Xin Cheng, Lingyan Meng, Darryl Chai Min Shen, Boon Wee Teo, Valerie Ma, Carol Anne Hargreaves\",\"doi\":\"10.1177/11297298221095769\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Creation and maintenance of dialysis vascular access (VA) is a major component of healthcare resource utilization and cost for patients newly started on hemodialysis (HD). Different VA format arises due to patient acceptance of anticipatory care versus late preparation, and clinical characteristics. This study reviews the clinical journey and resource utilization required for different VA formats in the first year of HD.</p><p><strong>Method: </strong>Data of patients newly commenced on HD between July 2015 and June 2016 were reviewed. Patients were grouped by their VA format: (A) pre-emptive surgically created VA (SCVA), (B) tunneled central venous catheter (CVC) followed by SCVA creation, (C) long-term tunneled CVC only. Clinical events, number of investigations and procedures, hospital admissions, and incurred costs of the three groups were compared.</p><p><strong>Results: </strong>In the multivariable analysis, the cost incurred by the group A patients had no significant difference to that incurred in the group B patients (<i>p</i> = 0.08), while the cost of group C is significantly lower (<i>p</i> < 0.001). Both the 62.7% of group A with successful SCVA who avoided tunneled CVC usage, and those with a functionally matured SCVA in group B (66.1%), used fewer healthcare resources and incurred less cost for their access compared to those did not (<i>p</i> = 0.01, <i>p</i> = 0.02, respectively) during the first year of HD.</p><p><strong>Conclusion: </strong>With comparable cost, a pre-emptive approach enables avoidance of tunneled CVC. Tunneled CVC only access format incurred lower cost and is suitable for carefully selected patients. Successful maturation of SCVA greatly affects patients' clinical journey and healthcare cost.</p>\",\"PeriodicalId\":35321,\"journal\":{\"name\":\"JAVA - Journal of the Association for Vascular Access\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAVA - Journal of the Association for Vascular Access\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/11297298221095769\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/5/11 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAVA - Journal of the Association for Vascular Access","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11297298221095769","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/5/11 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
背景:透析血管通路(VA)的建立和维护是新开始血液透析(HD)患者医疗资源利用和成本的主要组成部分。由于患者对预期护理和后期准备的接受程度以及临床特点的不同,会产生不同的血管通路形式。本研究回顾了血液透析第一年中不同形式的 VA 所需的临床过程和资源利用情况:回顾了 2015 年 7 月至 2016 年 6 月期间新开始接受 HD 治疗的患者数据。患者按其VA形式分组:(A)先期手术创建VA(SCVA),(B)隧道式中心静脉导管(CVC)后创建SCVA,(C)仅长期隧道式CVC。比较了三组患者的临床事件、检查和手术次数、住院次数和产生的费用:结果:在多变量分析中,A 组患者的费用与 B 组患者的费用无显著差异(P = 0.08),而 C 组患者在高清治疗第一年的费用显著较低(分别为 P = 0.01、P = 0.02):结论:在费用相当的情况下,先发制人的方法可避免使用隧道式 CVC。仅隧道式 CVC 入路方式的成本较低,适用于精心挑选的患者。SCVA 的成功成熟将极大地影响患者的临床旅程和医疗成本。
The clinical journey and healthcare resources required for dialysis access of end-stage kidney disease patients during their first year of hemodialysis.
Background: Creation and maintenance of dialysis vascular access (VA) is a major component of healthcare resource utilization and cost for patients newly started on hemodialysis (HD). Different VA format arises due to patient acceptance of anticipatory care versus late preparation, and clinical characteristics. This study reviews the clinical journey and resource utilization required for different VA formats in the first year of HD.
Method: Data of patients newly commenced on HD between July 2015 and June 2016 were reviewed. Patients were grouped by their VA format: (A) pre-emptive surgically created VA (SCVA), (B) tunneled central venous catheter (CVC) followed by SCVA creation, (C) long-term tunneled CVC only. Clinical events, number of investigations and procedures, hospital admissions, and incurred costs of the three groups were compared.
Results: In the multivariable analysis, the cost incurred by the group A patients had no significant difference to that incurred in the group B patients (p = 0.08), while the cost of group C is significantly lower (p < 0.001). Both the 62.7% of group A with successful SCVA who avoided tunneled CVC usage, and those with a functionally matured SCVA in group B (66.1%), used fewer healthcare resources and incurred less cost for their access compared to those did not (p = 0.01, p = 0.02, respectively) during the first year of HD.
Conclusion: With comparable cost, a pre-emptive approach enables avoidance of tunneled CVC. Tunneled CVC only access format incurred lower cost and is suitable for carefully selected patients. Successful maturation of SCVA greatly affects patients' clinical journey and healthcare cost.
期刊介绍:
The Association for Vascular Access (AVA) is an association of healthcare professionals founded in 1985 to promote the emerging vascular access specialty. Today, its multidisciplinary membership advances research, professional and public education to shape practice and enhance patient outcomes, and partners with the device manufacturing community to bring about evidence-based innovations in vascular access.